Corcept Therapeutics
CORT
#3417
Rank
S$5.15 B
Marketcap
S$48.45
Share price
-2.41%
Change (1 day)
-36.18%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: S$5.15 Billion

As of March 2026 Corcept Therapeutics has a market cap of S$5.15 Billion. This makes Corcept Therapeutics the world's 3417th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.15 B-53.91%
2025S$11.18 B49.63%
2024S$7.47 B69%
2023S$4.42 B50.86%
2022S$2.93 B-5.16%
2021S$3.09 B-23.13%
2020S$4.02 B115.16%
2019S$1.86 B-11%
2018S$2.09 B-23.84%
2017S$2.75 B136.29%
2016S$1.16 B51.05%
2015S$0.77 B92.16%
2014S$0.40 B-1.02%
2013S$0.40 B132.65%
2012S$0.17 B-53.21%
2011S$0.37 B3.63%
2010S$0.36 B47.65%
2009S$0.24 B235.9%
2008S$72.58 M-58.72%
2007S$0.17 B262.33%
2006S$48.53 M-64.73%
2005S$0.13 B-40.4%
2004S$0.23 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Corcept Therapeutics was reported to be:

S$5.15 Billion
by Nasdaq info icon info icon
S$5.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$746.63 B 14,387.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$369.08 B 7,061.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$198.18 B 3,745.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.012 T 19,552.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$381.10 B 7,294.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$154.00 B 2,888.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.90 B-82.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.90 B-82.41%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.41 B 160.33%๐Ÿ‡บ๐Ÿ‡ธ USA